• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,772.55(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Oxygenta Pharmaceutical Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 19443.0
  • ISIN : INE102E01018
85.05 4 (4.70%)
  • As on 25 Apr 2025 (EOD)

  • Today’s Low

    82.00

  • Today’s High

    89.35

  • Open

    87.69

  • Perv Close

    81.23

  • 52W Low

    30.00

  • 52W High

    108.64

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    314.54

  • Div & Yield %

    0.00

  • Book Value(₹)

    -5.11

  • Debt-Equity Ratio

    4.70

  • AGM Date

    25-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    314.54

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    36.98

  • BV (₹)

    -5.10

  • Sales( ₹ in Cr.)

    39.64

  • NP (in Cr.)

    -3.52

  • NP Var(%)

    68.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -1.00

  • Traded Value (₹ in Lakhs)

    300.42

  • 52 Week High

    108.64

  • 52 Week Low

    30.00

  • Price BSE

    81.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    300.42

  • P/C Ratio

    -350.10

  • P/E Ratio

    -85.20

  • Price Vs.BV

    -1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 39.64 30.99 60.52 52.03 13.72 20.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 39.64 30.99 60.52 52.03 13.72 20.51
Other Income 0.10 0.14 1.36 2.28 4.02 0.31
Stock Adjustments 1.53 4.63 -4.55 6.39 -0.59 1.67
Total Income 41.27 35.76 57.33 60.70 17.15 22.49
EXPENDITURE :            
Raw Materials 35.06 28.64 42.67 43.02 14.99 17.75
Power and Fuel Cost 4.15 4.16 3.04 2.79 1.00 0.89
Employee Cost 5.87 5.74 0.58 4.08 2.50 2.71
Other Manufacturing Expenses 3.28 2.43 6.31 2.88 1.32 1.38
Selling and Administration Expenses 2.48 1.75 1.88 1.79 1.17 1.43
Miscellaneous Expenses 0.04 0.87 0.82 0.01 0.01 0.06
Employee Benefit Expenses 5.87 5.74 0.58 4.08 2.50 2.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 50.89 43.59 55.31 54.57 20.99 24.22
Operating Profit -9.62 -7.83 2.02 6.12 -3.85 -1.72
Interest 1.59 1.49 0.92 1.78 1.09 0.75
Gross Profit -11.21 -9.32 1.10 4.34 -4.94 -2.47
Depreciation 2.66 2.05 1.59 1.20 1.00 1.02
Profit Before Tax -13.87 -11.37 -0.49 3.14 -5.94 -3.49
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.39 0.20 0.12 0.21 -0.15 -0.24
Reported Net Profit -3.48 -11.57 -0.61 2.93 -5.79 -3.25
Extraordinary Items 0.04 -0.72 0.43 2.04 3.99 0.00
Adjusted Net Profit -3.52 -10.85 -1.04 0.89 -9.78 -3.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -60.40 -48.83 -48.22 -51.15 -45.36 -42.11
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -63.88 -60.40 -48.83 -48.22 -51.15 -45.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.04 -8.15 -0.43 2.87 -5.67 -3.19
Earnings Per Share(Adj)-Unit Curr -1.04 -8.15 -0.43 - - -
Book Value -6.18 -32.53 -24.38 -37.27 -40.14 -34.47
Book Value(Adj)-Unit Curr -6.18 -32.53 -24.38 - - -

Shareholding Pattern

  • Promoter Group

    51.12%

  • Public Share Holding

    48.88%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 200,000 0.54 200,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,706,202 50.58 18,706,202 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,906,202 51.12 18,906,202 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 9,700 0.03 0 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,700 0.03 0 3
2] Non Institution
Bodies Corporate 114,972 0.31 97,272 86
Clearing Members 4,601 0.01 4,601 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,702,168 4.60 1,700,168 16
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,352,812 36.10 13,330,812 42
Individuals holding nominal share capital up to Rs. 1 lakh 2,893,045 7.82 1,612,015 9,866
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,067,598 48.85 16,744,868 10,016
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 36,983,500 100.00 35,651,070 10,030

Company Background

Oxygenta Pharmaceutical LtdPharmaceuticals - Indian - Bulk Drugs

  • Oxygenta Pharmaceutical Ltd
  • BSE Code : 19443.0
  • ISIN : INE102E01018

  • Incorporation Year

    1990

  • Registered Office

    Survey No 252/1 Aroor Village
    Sadasivapet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-08455-250080/250280

  • FAX

    91-08455-250090

  • Chairman

    Sai Sudhakar Vankineni

  • Managing Director

    Sai Sudhakar Vankineni

  • Company Secretary

    Dolly Mandhan

  • Auditor

    A M Reddy & D R Reddy

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Oxygenta Pharmaceutical Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Oxygenta Pharma 85.05 39.68 39.64 -2,126.25 0.00
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92